Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

2003/10/01 by Markku Saraheimo, M. Saraheimo, A.-M. Teppo +6 · 28 citations
Medicine · #Chronic Kidney Disease and Diabetes #Inflammatory Biomarkers in Disease Prognosis #Adipokines, Inflammation, and Metabolic Diseases

paper · pdf · doi:10.1007/s00125-003-1194-5

Citations

• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Cited by

• Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes
• Inflammation and the pathogenesis of diabetic nephropathy
• Association between chronic low-grade inflammation and metabolic syndrome and their impact on the risk of coronary artery disease in type 1 diabetes
• Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. [europepmc]
• What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? [europepmc]
• Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. [europepmc]
• An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients. [europepmc]
• Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. [europepmc]
• The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. [europepmc]
• The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. [europepmc]
• Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study). [europepmc]
• Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. [europepmc]
• Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy. [europepmc]
• Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. [europepmc]
• Association between IL-6 concentration and diabetes-related variables in DM1 patients with and without microvascular complications. [europepmc]
• The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes. [europepmc]
• Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. [europepmc]
• Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals. [europepmc]
• Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes. [europepmc]
• Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. [europepmc]
• Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study. [europepmc]
• Biomarkers of Renal Disease and Progression in Patients with Diabetes. [europepmc]
• DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats. [europepmc]
• Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. [europepmc]
• Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease. [europepmc]
• The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders. [europepmc]
• Epigenetics and Inflammation in Diabetic Nephropathy. [europepmc]
• Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. [europepmc]